Citation

Hakan N, Aydin M, Ozdiller S, Zenciroglu A, Okumus N. Acta Paediatr. 2013; 102(12): e530-1.

Affiliation

Division of Neonatology, Department of Paediatrics, Erzurum Training and Research Hospital, Erzurum, Turkey.

Copyright

(Copyright © 2013, John Wiley and Sons)

DOI

10.1111/apa.12414

PMID

24015962

Abstract

We read with great interest the paper by Austin et al (1) that evaluated the impact of in utero exposure to antidepressant drugs on infants' neurodevelopment. Using the Bayley Scales of Infant Development (BSID-III) to assess neurodevelopmental at 18-months-of-age, they reported that in utero exposure to antidepressants - mostly serotonin reuptake inhibitors (SRIs) - had no impact on cognitive, motor, and/or language development outcomes. This article is protected by copyright. All rights reserved.

Language: en